Qiagen Registers $127.1M in Employee Stock Options | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen on Thursday filed for the registration of up to $127.1 million in shares in connection to stock options being offered to employees.

The company filed a registration for 9 million shares at a proposed maximum offering price of $14.12 in a Form S-8 filed with the US Securities and Exchange Commission.

The price was based on the average of the high and low sale prices of Qiagen's stock as of Nov. 15, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.